MILLER VALUE PARTNERS, LLC

Company

Alaunos Therapeutics, Inc.

Filed

February 14, 2019

Accession Number

0001085146-19-000809

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →